Received Apr 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | UNK | 3CA22C1 | — |
adacel that was given to a patient last friday, 6 days past the expiration with no reported adverse event; Initial information received on 09-Mar-2026 regarding an unsolicited valid non-serious case received from a Nurse This case involves a patient of unknown age and unknown gender who was given diphtheria, tetanus and acellular pertussis vaccine (ADACEL) last Friday, 6 days past the expiration with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication, and family history were not provided. On 06-Mar-2026, the patient started taking diphtheria, tetanus and acellular pertussis vaccine (ADACEL) suspension for injection (strength, dose, frequency, route, site unknown) for immunization 6 days past the expiration with no reported adverse event [(Expired product administered, latency: same day) (batch: 3CA22C1, expiry: 28-Feb-2026)]. Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Comments: NONE